CONSORT-like diagram. Patient disposition according to MRD status throughout the TOURMALINE-MM3 and -MM4 trials. ∗Patients with less than a CR and missing MRD data were imputed as MRD⁺; ongoing patients in CR and missing MRD data were classified as “missing”. †Post-randomization is at any time point from randomization until end of treatment.